Byte Beautiful: Eight Science Fiction Stories

Zymo Research's DNA/RNA Shield™ Inactivates Monkeypox for the Collection and Transportation of Samples

Retrieved on: 
Thursday, July 14, 2022

This data comes at a critical time as Monkeypox cases continue to climb worldwide and scientists are seeking methods to safely collect and transport samples without compromising the genetic integrity.

Key Points: 
  • This data comes at a critical time as Monkeypox cases continue to climb worldwide and scientists are seeking methods to safely collect and transport samples without compromising the genetic integrity.
  • The DNA/RNA Shield product line includes sample collection, preservation, and transportation devices for specimens used in research and infectious disease testing workflows.
  • DNA/RNA Shield has enabled researchers to conduct infectious disease research and testing over the past decade, including throughout the COVID-19 pandemic.
  • Zymo Research offers several devices that can be filled with DNA/RNA Shield, including the popular SafeCollect Swab Collection Kit.

Zymo Research's DNA/RNA Shield™ Inactivates Monkeypox for the Collection and Transportation of Samples

Retrieved on: 
Thursday, July 14, 2022

This data comes at a critical time as Monkeypox cases continue to climb worldwide and scientists are seeking methods to safely collect and transport samples without compromising the genetic integrity.

Key Points: 
  • This data comes at a critical time as Monkeypox cases continue to climb worldwide and scientists are seeking methods to safely collect and transport samples without compromising the genetic integrity.
  • The DNA/RNA Shield product line includes sample collection, preservation, and transportation devices for specimens used in research and infectious disease testing workflows.
  • DNA/RNA Shield has enabled researchers to conduct infectious disease research and testing over the past decade, including throughout the COVID-19 pandemic.
  • Zymo Research offers several devices that can be filled with DNA/RNA Shield, including the popular SafeCollect Swab Collection Kit.

Zymo Research Launches Operations in South America, Increasing its Footprint in the Global Marketplace

Retrieved on: 
Tuesday, May 24, 2022

Zymo Research South America will officially open on July 4, 2022, with an open house for partners, local politicians, universities, and local scientists.

Key Points: 
  • Zymo Research South America will officially open on July 4, 2022, with an open house for partners, local politicians, universities, and local scientists.
  • This marks the latest addition to Zymo Research's existing operations network located in the United States, Europe, and China.
  • Zymo Research's new office will provide personalized services in Portuguese, Spanish, and English to meet the needs of the region and other global operations.
  • Dr. Marc Van Eden, Vice President of Business Development of Zymo Research, said, "Our customers are seeing the value and agility that Zymo Research can provide.

Zymo Research Makes Strategic Investment in Star Array to Develop an Automated Nucleic Acid Extraction/Superfast PCR Platform for the POCT Market

Retrieved on: 
Wednesday, April 27, 2022

IRVINE, Calif., April 26, 2022 /PRNewswire/ -- Zymo Research and Star Array today announced Zymo Research's strategic investment to acquire an interest in Star Array, a privately owned, biomedical technology company based in Singapore.

Key Points: 
  • IRVINE, Calif., April 26, 2022 /PRNewswire/ -- Zymo Research and Star Array today announced Zymo Research's strategic investment to acquire an interest in Star Array, a privately owned, biomedical technology company based in Singapore.
  • The investment allows Zymo Research and Star Array to combine Zymo Research's nucleic acid purification and assay technologies with Star Array's engineering and automation expertise to expand into emerging For Research Use Only (FRUO) and diagnostic markets including Point-of-Care testing (POCT).
  • Star Array'sfocus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology.
  • Zymo Research will be partnering with Star Array to develop ready-made cassettes containing the necessary reagents for Star Array's COVID-19 test kit as well as future POCT.

Zymo Research Makes Strategic Investment in Star Array to Develop an Automated Nucleic Acid Extraction/Superfast PCR Platform for the POCT Market

Retrieved on: 
Wednesday, April 27, 2022

IRVINE, Calif., April 27, 2022 /PRNewswire/ -- Zymo Research and Star Array today announced Zymo Research's strategic investment to acquire an interest in Star Array, a privately owned, biomedical technology company based in Singapore.

Key Points: 
  • IRVINE, Calif., April 27, 2022 /PRNewswire/ -- Zymo Research and Star Array today announced Zymo Research's strategic investment to acquire an interest in Star Array, a privately owned, biomedical technology company based in Singapore.
  • The investment allows Zymo Research and Star Array to combine Zymo Research's nucleic acid purification and assay technologies with Star Array's engineering and automation expertise to expand into emerging For Research Use Only (FRUO) and diagnostic markets including Point-of-Care testing (POCT).
  • Star Array'sfocus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology.
  • Zymo Research will be partnering with Star Array to develop ready-made cassettes containing the necessary reagents for Star Array's COVID-19 test kit as well as future POCT.

Zymo Research Partners With YARD Sciences to Expand Scientific Access to High School Students in Underserved Communities

Retrieved on: 
Wednesday, December 8, 2021

IRVINE, Calif., Dec. 8, 2021 /PRNewswire/ -- Zymo Research announced today that it is partnering with YARD Sciences to give high school students up-close and personal experiences with scientific laboratories.

Key Points: 
  • IRVINE, Calif., Dec. 8, 2021 /PRNewswire/ -- Zymo Research announced today that it is partnering with YARD Sciences to give high school students up-close and personal experiences with scientific laboratories.
  • Zymo Research has donated $10,000 to YARD Sciences to help purchase vitally needed laboratory equipment to support YARD Sciences' mission to provide students with a deep educational experience in the sciences.
  • YARD Sciences provides experiences with biomolecular and genetic engineering, human anatomy and physiology, and surgical subspecialties to high school students.
  • We are grateful to be able to partner with YARD Sciences, an organization that provides opportunities for high school students in underserved communities so they can excel in research.

Zymo Research Receives CE IVD Mark for its EZ DNA Methylation-Lightning Kit

Retrieved on: 
Thursday, September 23, 2021

IRVINE, Calif., Sept. 23, 2021 /PRNewswire/ -- Today Zymo Research announced its EZ DNA Methylation-Lightning Kit™ has received the CE IVD Mark allowing the technology to be distributed within the European Union (EU) common market. Chemical treatment of DNA with bisulfite is the prerequisite for many methylation-based diagnostic assays. Clinical diagnostic and screening tests, particularly those for cancer and developmental diseases, are now utilizing methylation profiling of DNA to detect the presence of disease and guide treatment.

Key Points: 
  • IRVINE, Calif., Sept. 23, 2021 /PRNewswire/ --Today Zymo Research announced its EZ DNA Methylation-Lightning Kit has received the CE IVD Mark allowing the technology to be distributed within the European Union (EU) common market.
  • The EZ DNA Methylation-Lightning Kit features a ready-to-use conversion reagent, which streamlines the workflow for completion in a little over an hour.
  • The EZ DNA Methylation-Lightning Kit is one example of this philosophy," said Marc Van Eden, Zymo Research's Vice President of Business Development.
  • For more information about the EZ DNA Methylation-Lightning Kit, visit Zymo Research's website .

Zymo Research Receives CE IVD Mark for its EZ DNA Methylation-Lightning Kit

Retrieved on: 
Thursday, September 23, 2021

IRVINE, Calif., Sept. 22, 2021 /PRNewswire/ --Today Zymo Research announced its EZ DNA Methylation-Lightning Kit has received the CE IVD Mark allowing the technology to be distributed within the European Union (EU) common market.

Key Points: 
  • IRVINE, Calif., Sept. 22, 2021 /PRNewswire/ --Today Zymo Research announced its EZ DNA Methylation-Lightning Kit has received the CE IVD Mark allowing the technology to be distributed within the European Union (EU) common market.
  • The EZ DNA Methylation-Lightning Kit features a ready-to-use conversion reagent, which streamlines the workflow for completion in a little over an hour.
  • The EZ DNA Methylation-Lightning Kit is one example of this philosophy," said Marc Van Eden, Zymo Research's Vice President of Business Development.
  • For more information about the EZ DNA Methylation-Lightning Kit, visit Zymo Research's website .